drugset / Trial / NCT00325260
Non-Inferiority Study Comparing the Subunit Vaccines Influvac and Agrippal in China
RandomizedParallel-groupDouble-blindPrevention
Summary
In the study Influvac will be compared to Agrippal, another subunit influenza vaccine that is already on the market in China. The main objective of the study is to show that both vaccines are comparable with regard to efficacy. In addition, safety and efficacy data with Influvac will be assessed in the Chinese population.
Timeline
- Start
- 2006-03
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Influenza Virus Vaccine | Vaccine | — | — |
Indications
No indication recorded.